Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.79 |
| ▸ | DHODH | Q02127 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | GFER | P55789 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | STAT1 | P42224 | 1/20 | 0.63 |
| ▸ | SMO | Q99835 | 2/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.61 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.61 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.61 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1336628 | 1.00 | ALDH1A1 (0.79) | ALDH1A1DHODHMEN1KMT2AMAPT | |
| SCHEMBL13927135 | 0.92 | ALDH1A1 (0.92) | ALDH1A1DHODHMEN1KMT2AGFER | |
| SCHEMBL13927142 | 0.89 | MEN1 (0.74) | ALDH1A1DHODHMEN1KMT2AGFER | |
| SCHEMBL1991348 | 0.88 | ALDH1A1 (1.00) | ALDH1A1MEN1KMT2AGFERKDM4E | |
| SCHEMBL45299 | 0.88 | ALDH1A1 (1.00) | ALDH1A1MEN1KMT2AGFERKDM4E | |
| SCHEMBL18132360 | 0.87 | SMO (0.60) | ALDH1A1DHODHMEN1KMT2AHPGD | |
| SCHEMBL15928756 | 0.87 | ALDH1A1 (0.72) | ALDH1A1DHODHMEN1KMT2AMAPT | |
| SCHEMBL12189649 | 0.85 | ALDH1A1 (0.85) | ALDH1A1MEN1KMT2AMAPTGFER | |
| SCHEMBL2058694 | 0.85 | ALDH1A1 (0.79) | ALDH1A1MEN1KMT2AGFERKDM4E | |
| SCHEMBL12046468 | 0.84 | ALDH1A1 (0.66) | ALDH1A1DHODHMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746852-A1 | LIPID AGGREGATES FOR INTRAARTICULAR ADMINISTRATION | Universität Bern (CH) | 2026-05-27 | — | — | EP | claimed |
| CN-121197040-B | In-situ carrier hydrogel based on nano bottle packaging technology and preparation method and application thereof | 上海大学 | 2026-05-19 | — | — | CN | claimed |
| CN-121586573-A | Lipopolymers for intra-articular administration | 伯尔尼大学 | 2026-02-27 | — | — | CN | claimed |
| US-20260041819-A1 | TUNABLE, BIOCOMPATIBLE, NANOPARTICLE-CROSSLINKED HYALURONIC ACID-TYPE I COLLAGEN HYDROGEL USING DIELS-ALDER CLICK CHEMISTRY FOR REGENERATIVE MEDICINE APPLICATIONS | CLARKSON UNIVERSITY (US) | 2026-02-12 | — | — | US | claimed |
| US-20260023070-A1 | OPTOGENETIC ALPHA-SYNUCLEIN AGGREGATION SYSTEM-BASED COMPOUND SCREENING PLATFORM IN PD-hiPSC-mDA NEURONS | UNIV JOHNS HOPKINS (US) | 2026-01-22 | — | — | US | claimed |
| US-20250339520-A1 | COMPOSITIONS AND METHODS FOR USE IN KRAS-TARGETED THERAPIES FOR THE TREATMENT OF CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-11-06 | — | — | US | claimed |
| US-20250295643-A1 | METHODS OF TREATING EPILEPSY | UNIV YALE (US) | 2025-09-25 | — | — | US | claimed |
| EP-4618966-A2 | STABILIZED BLOOD DERIVED COMPOSITION USING ANTIFIBRINOLYTIC AGENTS | Turzi, Antoine (CH) | 2025-09-24 | — | — | EP | claimed |
| CN-120053685-A | KGN-loaded nano vesicle, dissoluble microneedle and preparation method and application thereof | 重庆科技大学 | 2025-05-30 | — | — | CN | claimed |
| US-20250082827-A1 | TRILAYERED BIOMIMETIC HYDROGEL SCAFFOLDS OF DUAL MICROENVIRONMENT AND PREPARATION METHOD AND APPLICATION THEREOF | XINXIANG MEDICAL COLLEGE (CN) | 2025-03-13 | — | — | US | claimed |
| CN-112831462-B | Compositions, media and methods for inducing reprogramming of human cells to induced pluripotent stem cells | 复旦大学 | 2022-10-18 | — | — | CN | claimed |
| CN-115054579-A | Nanoparticle arthritis drug with active oxygen responsive gradient drug delivery and preparation method thereof | 浙江大学 | 2022-09-16 | — | — | CN | claimed |
| CN-112807489-B | Injectable acellular scaffold for cartilage repair and preparation method and application thereof | 广东省人民医院 | 2022-09-13 | — | — | CN | claimed |
| US-11427808-B2 | Method for serum-free culture of chondrocytes and serum-free culture medium | REGENESIS SCIENCE CO., LTD. (JP) | 2022-08-30 | — | — | US | claimed |
| WO-2022174071-A2 | RECONSTITUTION OF EXTRACELLULAR MATRIXES FOR MUSCULOSKELETAL JOINT TISSUE REPAIR USING BIOMIMETIC BIOLOGIC AND SYNTHETIC FACTORS | RHODE ISLAND HOSPITAL (US) | 2022-08-18 | — | — | WO | claimed |
| US-20220257572-A1 | METHODS OF TREATING EPILEPSY | YALE UNIVERSITY | 2022-08-18 | — | — | US | claimed |
| US-20220211683-A1 | NOVEL MATERIAL FOR SKIN WOUND CLOSURE AND SCAR PREVENTION | THE UNIVERSITY OF CHICAGO (US) | 2022-07-07 | — | — | US | claimed |
| CN-114699562-A | Hydrogel and preparation method and application thereof | 南方科技大学 | 2022-07-05 | — | — | CN | claimed |
| CN-111588705-B | Mesenchymal stem cell membrane camouflage magnetic drug-loaded nanoparticle and preparation method and application thereof | 复旦大学附属华山医院 | 2022-07-05 | — | — | CN | claimed |
| CN-114652856-A | Dual-protein delivery carrier programmed drug delivery system and preparation method thereof | 西北大学 | 2022-06-24 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041819-A1 | TUNABLE, BIOCOMPATIBLE, NANOPARTICLE-CROSSLINKED HYALURONIC ACID-TYPE I COLLAGEN HYDROGEL USING DIELS-ALDER CLICK CHEMISTRY FOR REGENERATIVE MEDICINE APPLICATIONS | CD44, COL2A1, COL1A1 | ALDH1A1 4/4885DHODH 604/4885MEN1 1752/4885 |
| US-20220257572-A1 | METHODS OF TREATING EPILEPSY | FLNA, EPM2A, PFN1 | ALDH1A1 2939/4885DHODH 3118/4885MEN1 889/4885 |
| US-20260023070-A1 | OPTOGENETIC ALPHA-SYNUCLEIN AGGREGATION SYSTEM-BASED COMPOUND SCREENING PLATFORM IN PD-hiPSC-mDA NEURONS | SNCA, MAP1LC3B, MAPT | ALDH1A1 2575/4885DHODH 2738/4885MEN1 4168/4885 |
| US-20250295643-A1 | METHODS OF TREATING EPILEPSY | FLNA, EPM2A, PFN1 | ALDH1A1 2939/4885DHODH 3118/4885MEN1 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.